Ayalon Insurance Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-19,320
| Closed | -$1.44M | – | 111 |
|
|
2022
Q2 | $1.44M | Buy |
+19,320
| New | +$1.44M | 0.68% | 38 |
|
|
2022
Q1 | – | Sell |
-2,350
| Closed | -$263K | – | 142 |
|
|
2021
Q4 | $263K | Hold |
2,350
| – | – | 0.09% | 96 |
|
|
2021
Q3 | $296K | Sell |
2,350
-4,034
| -63% | -$508K | 0.11% | 93 |
|
|
2021
Q2 | $884K | Sell |
6,384
-6,130
| -49% | -$849K | 0.29% | 72 |
|
|
2021
Q1 | $1.72M | Buy |
12,514
+15
| +0.1% | +$2.06K | 0.67% | 47 |
|
|
2020
Q4 | $1.76M | Hold |
12,499
| – | – | 0.8% | 38 |
|
|
2020
Q3 | $1.4M | Sell |
12,499
-2,950
| -19% | -$330K | 0.77% | 36 |
|
|
2020
Q2 | $1.74M | Buy |
15,449
+14,780
| +2,209% | +$1.66M | 1.01% | 31 |
|
|
2020
Q1 | $49K | Hold |
669
| – | – | 0.04% | 95 |
|
|
2019
Q4 | $64K | Sell |
669
-84
| -11% | -$8.04K | 0.04% | 100 |
|
|
2019
Q3 | $56K | Sell |
753
-595
| -44% | -$44.3K | 0.04% | 103 |
|
|
2019
Q2 | $119K | Hold |
1,348
| – | – | 0.08% | 71 |
|
|
2019
Q1 | $122K | Sell |
1,348
-150
| -10% | -$13.6K | 0.09% | 66 |
|
|
2018
Q4 | $107K | Sell |
1,498
-12,447
| -89% | -$889K | 0.09% | 67 |
|
|
2018
Q3 | $1.3M | Sell |
13,945
-10,550
| -43% | -$984K | 1.04% | 28 |
|
|
2018
Q2 | $2.33M | Buy |
24,495
+8,295
| +51% | +$790K | 1.95% | 14 |
|
|
2018
Q1 | $1.42M | Buy |
16,200
+400
| +3% | +$35.1K | 1.18% | 22 |
|
|
2017
Q4 | $1.34M | Buy |
+15,800
| New | +$1.34M | 1.09% | 20 |
|